WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (64)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helgren, M. E.
Right arrow Articles by Lindsay, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helgren, M. E.
Right arrow Articles by Lindsay, R. M.

 Previous Article  |  Next Article 

Volume 17, Number 1, Issue of January 1, 1997 pp. 372-382
Copyright ©1997 Society for Neuroscience

Neurotrophin-3 Administration Attenuates Deficits of Pyridoxine-Induced Large-Fiber Sensory Neuropathy

Received June 27, 1996; revised Oct. 18, 1996; accepted Oct. 22, 1996.

Maureen E. Helgren, Kenneth D. Cliffer, Kim Torrento, Chris Cavnor, Rory Curtis, Peter S. DiStefano, Stanley J. Wiegand, and Ronald M. Lindsay

Regeneron Pharmaceuticals, Inc., Tarrytown, New York 10591-6707

Chronic treatment of adult rats for 2-3 weeks with high doses of pyridoxine (vitamin B6) produced a profound proprioceptive loss, similar to that found in humans overdosed with this vitamin or treated with the chemotherapeutic agent cisplatin. Pyridoxine toxicity was manifest as deficits in simple and precise locomotion and sensory nerve function and as degeneration of large-diameter/large-fiber spinal sensory neurons. As assessed quantitatively in a beam-walking task and by EMG recording of H waves evoked by peripheral nerve stimulation, coadministration of the neurotrophic factor neurotrophin-3 (NT-3; 5-20 mg · kg-1 · d-1, s.c.) during chronic pyridoxine treatment largely attenuated the behavioral and electrophysiological sequelae associated with pyridoxine toxicity. Furthermore, NT-3 administration prevented degeneration of sensory fibers in the dorsal column of the spinal cord. These data are consistent with the evidence that NT-3 is a target-derived neurotrophic factor for muscle sensory afferents and suggest that pharmacological doses of NT-3 may be beneficial in the treatment of large-fiber sensory neuropathies.

Key words: NT-3; sensory neuropathy; proprioception; DRG; pyridoxine; sensory-motor function




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
T.-T. Yang and S.-J. Wang
Pyridoxine Inhibits Depolarization-Evoked Glutamate Release in Nerve Terminals from Rat Cerebral Cortex: a Possible Neuroprotective Mechanism?
J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 244 - 254.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
V. S. Boyce, M. Tumolo, I. Fischer, M. Murray, and M. A. Lemay
Neurotrophic Factors Promote and Enhance Locomotor Recovery in Untrained Spinalized Cats
J Neurophysiol, October 1, 2007; 98(4): 1988 - 1996.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. E. Pleasure and P. F. Chance
Neurotrophin-3 therapy for Charcot-Marie-Tooth disease type 1A
Neurology, September 13, 2005; 65(5): 662 - 663.
[Full Text] [PDF]


Home page
NeurologyHome page
Z. Sahenk, H. N. Nagaraja, B. S. McCracken, W. M. King, M. L. Freimer, J. M. Cedarbaum, and J. R. Mendell
NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients
Neurology, September 13, 2005; 65(5): 681 - 689.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. M. Sayers, L. J. Beswick, A. Middlemas, N. A. Calcutt, A. P. Mizisin, D. R. Tomlinson, and P. Fernyhough
Neurotrophin-3 Prevents the Proximal Accumulation of Neurofilament Proteins in Sensory Neurons of Streptozocin-Induced Diabetic Rats
Diabetes, September 1, 2003; 52(9): 2372 - 2380.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. M Mendell, J. B Munson, and V. L Arvanian
Neurotrophins and synaptic plasticity in the mammalian spinal cord
J. Physiol., May 15, 2001; 533(1): 91 - 97.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. M. Mendell, R. D. Johnson, and J. B. Munson
Neurotrophin Modulation of the Monosynaptic Reflex after Peripheral Nerve Transection
J. Neurosci., April 15, 1999; 19(8): 3162 - 3170.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A J Kennedy, A Wellmer, P Facer, G Saldanha, P Kopelman, R M Lindsay, and P Anand
Neurotrophin-3 is increased in skin in human diabetic neuropathy
J. Neurol. Neurosurg. Psychiatry, September 1, 1998; 65(3): 393 - 395.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
M. Malcangio, N. E. Garrett, S. Cruwys, and D. R. Tomlinson
Nerve Growth Factor- and Neurotrophin-3-Induced Changes in Nociceptive Threshold and the Release of Substance P from the Rat Isolated Spinal Cord
J. Neurosci., November 1, 1997; 17(21): 8459 - 8467.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-